Anthem (ANTM) Added to Citi's Focus List

Leerink Partners Cuts Price Target Following Anthem's (ANTM) Mixed 4Q Results

January 28, 2016 8:23 AM EST

Leerink Partners maintained an Outperform rating on Anthem (NYSE: ANTM), and cut the price target to $190.00 (from $200.00), following the company's 4Q earnings report. 2015 adjusted EPS of $10.16 missed modestly from the previously disclosed shutdown of the Colorado Coop. 2016 EPS guidance floor of $10.80 was reaffirmed with upside on MLR and SG&A though at tepid top-line growth marked by HIX and Employer losses.

Analyst Ana Gupte commented, "We reiterate our OP rating on ANTM while lowering our PT to $190 (from $200) after a mixed 4Q. 2015 Adj. EPS of $10.16 ex items missed... More

Anthem (ANTM) Misses Q4 EPS by 8c

January 27, 2016 6:15 AM EST

Anthem (NYSE: ANTM) reported Q4 EPS of $1.14, $0.08 worse than the analyst estimate of $1.22. Revenue for the quarter came in at $20.02 billion versus the consensus estimate of $19.9 billion.

Medical enrollment totaled approximately 38.6 million members as of December 31, 2015 and increased by 1.1 million lives during... More

Health insurer Anthem says Obamacare costs drag down fourth-quarter profit

January 27, 2016 6:11 AM EST

By Caroline Humer

(Reuters) - Health insurer Anthem Inc (NYSE: ANTM), which is in the process of buying smaller rival Cigna Corp (NYSE: CI), said on Wednesday its individual Obamacare exchange health plans weighed on fourth-quarter profit, causing it to miss analysts' expectations.

Anthem said that it had nearly 800,000 people enrolled in plans through the exchanges, which were created under President Barack Obama's national healthcare reform law, about 30 percent below its expectations. Without the membership it had planned for, costs of running the business were too high,... More